Karol Bagh | GS Foundation Course | 16 February, 8 AM Call Us
This just in:

State PCS

Daily Updates


Governance

Re-establishment of PCIM&H

  • 04 Jun 2020
  • 3 min read

Why in News

Recently, the Union Cabinet has given its approval to re-establish Pharmacopoeia Commission for Indian Medicine and Homoeopathy (PCIM&H) as a subordinate office under the Ministry of AYUSH.

  • Pharmacopoeia Laboratory for Indian Medicine (PLIM) and Homoeopathic Pharmacopoeia Laboratory (HPL), central laboratories established at Ghaziabad (Uttar Pradesh) since 1975, will be merged into the PCIM&H.

Key Points

  • Presently, PCIM&H is an autonomous body under the aegis of Ministry of AYUSH, established since 2010.
  • Pharmacopoeia is an officially recognized book of standards as per the Drugs and Cosmetics Act, 1940 and Rules 1945 thereunder.
    • As per the Second Schedule of the Drugs and Cosmetics Act, it is designated as the official book of standards for drugs imported and/or manufactured for sale, stock or exhibition for sale or distribution in India.
    • It specifies the standards of drugs manufactured and marketed in India in terms of their identity, purity and strength.
  • The merger intends to accord legal status to the merged structure of PCIM&H and its laboratory by making the necessary amendments and enabling provisions in the Drugs and Cosmetics Rules, 1945.
    • Consultations have been done with the Director General Health Services, Drugs Controller General and the Ayurveda, Siddha and Unani Drugs Technical Advisory Board (ASUDTAB).
  • Benefits of the Merger:
    • Optimum use of infrastructural facilities, technical manpower and financial resources of the three organizations for enhancing their standardised outcomes.
    • Focused and cohesive development of standards of AYUSH drugs and publication of pharmacopoeias and formularies.

Ayurveda, Siddha and Unani Drugs Technical Advisory Board

  • ASUDTAB is a statutory body under the provisions of Drugs and Cosmetics Act, 1940.
  • It advises the central and state governments in regulatory matters of Accelerated Shelf Life Testing (ASLT) drugs.

Accelerated Shelf Life Testing

  • It is an indirect method of measuring and estimating the stability of a product by storing the product under controlled conditions that increase the rate of degradation occurring in the product under normal storage conditions.
  • ASLT is useful for a number of purposes like:
    • To predict product stability including colour.
    • To determine product safety under abuse conditions.
    • To troubleshoot in the initial stages of product development.
    • To assess the packaging performance of a product.

Source: PIB

close
SMS Alerts
Share Page
images-2
images-2